Condition
Malaria Fever
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
P 1 (1)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Not Yet Recruiting2
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07520279Enrolling By InvitationPrimary
Xpert® Tropical Fever Test on GeneXpert® Edge X System
NCT07456969Not Yet RecruitingPrimary
Non-invasive Malaria Diagnostic Data Collection in Ethiopia
NCT07436104Phase 4Completed
Mortality Control Program for Economically Productive Age Group in Tribal Area of Melghat.
NCT07124156Phase 1Not Yet RecruitingPrimary
A Challenge Study to Assess the Blood-stage Efficacy of Full-length SUM-101 Malaria Vaccine Candidate
NCT05192265Phase 2CompletedPrimary
Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine
Showing all 5 trials